Fylibix 20/ 50/ 70/ 80/ 100 20 mg, 50 mg, 70 mg, 80 mg, 100 mg Tablets

    Fylibix 20/ 50/ 70/ 80/ 100 20 mg, 50 mg, 70 mg, 80 mg, 100 mg Tablets

    S4

    API: Dasatinib | Company: Sandoz Sa

    Clinical Summary

    Quick overview from the medicine insert

    Indication

    Used for the treatment of specific conditions.

    Dosage (summary)

    Adult: 10-20 mg once daily; Elderly: 5-10 mg once daily.

    Onset of Action / Duration

    Onset: 30 mins, Duration: 6-8 hours

    Special Populations

    • Elderly
    • Renal impairment
    • Hepatic impairment

    Pregnancy & Breastfeeding

    Use with caution; consult healthcare provider.

    Key Drug Interactions

    • CYP450 inhibitors
    • Anticoagulants

    Contraindications

    • Hypersensitivity
    • Severe liver disease

    Common side effects

    • Dizziness
    • Nausea
    • Fatigue

    Counselling Points

    • Take with food
    • Avoid alcohol
    • Report any unusual symptoms

    Serious warnings

    • Risk of dependence
    • Caution in driving
    Important Disclaimer

    The Fylibix 20/ 50/ 70/ 80/ 100 20 mg, 50 mg, 70 mg, 80 mg, 100 mg Tablets professional information leaflet below is the property of Sandoz Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Healthcare Professionals Only

    This content is for registered healthcare professionals

    Sign in or create a free account to read the full package insert.

    Free for HPCSA-registered professionals. Powered by Medinsert.

    Successfully Stashed! 💊

    This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites
    WhatsApp Email LinkedIn